Drug details
Xatmep (methotrexate oral solution)
type of DMARDs, Immunomodulators, Antineoplastics, Antimetabolite
Xatmep (methotrexate) oral solution is a folate analog metabolic inhibitor indicated for the treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as a component of a combination chemotherapy maintenance regimen; and for management of pediatric patients with active polyarticular juvenile idiopathic arthritis (pJIA) who are intolerant of or had an inadequate response to first-line therapy.
The drug is often used to treat Arthritis .
This drug may have the following side effects:
- nausea,
- fatigue,
- feeling unwell (malaise),
- ulcerative stomatitis,
- low white blood cell count (leukopenia),
- abdominal distress,
- elevated liver function tests,
- chills and fever,
- dizziness and decreased resistance to infection.
The following drugs are related to Xatmep, either as a replacement or used together:
- Humira (adalimumab injection solution for subcutaneous administration)
- Otezla (apremilast tablets)
- Asacol (mesalamine delayed-release tablets)
- Asacol HD (mesalamine delayed-release tablets, oral)
- Azulfidine EN-Tabs (sulfasalazine delayed release tablets)
- Giazo (balsalazide disodium)
- Sernivo (betamethasone dipropionate spray, 0.05%)
- Luxiq (betamethasone valerate foam)
- Siliq (brodalumab injection for subcutaneous use)
- Cataflam (diclofenac potassium immediate-release tablets)
- Cimzia (certolizumab pegol injection)
- Olux (clobetasol propionate)
- Olux-E (clobetasol propionate foam)
- Clobex Spray (clobetasol propionate spray)
- Cosentyx (secukinumab injection)
- Sandimmune (cyclosporine)
- Delzicol (mesalamine delayed-release capsules)
- Raptiva (efalizumab)
- Vanos (fluocinonide)
- Ultravate Cream (halobetasol propionate)
- Remicade (infliximab)
- Medrol (methylprednisolone)
- Meloxicam Tablets (meloxicam)
- Rasuvo (methotrexate non-pyrogenic solution for a single subcutaneous injection)
- RediTrex (methotrexate injection)
- Rheumatrex (methotrexate tablets)
- Stelara Injection (ustekinumab)
- Triesence (triamcinolone acetonide injectable suspension)